Experimental psychopharmacologic study of a new psychotropic drug, 2-ethylamino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine
Boissier, J.R.; Simon, P.; Zaczinska, M.; Fichelle, J.
Therapie 27(2): 325-338
1972
ISSN/ISBN: 0040-5957 PMID: 5084676 Document Number: 44289
Document emailed within 1 workday
Related Documents
Pfeifer, S.; Bornschein, I.; Gehrke, A. 1977: Biotransformation of 2-phenyl-4-/beta-dimethylamino-ethyl/-6-methyl-2,3-dihydro-1,4-benzoxazine-3-one ("AR 17 O48) a potential antirheumatic agent Die Pharmazie 32(10): 587-592Brzozowski, Z.; Sławiński, J.; Angielski, S.; Szczepańska-Konkiel, M. 1985: Derivatives of 1,1-dioxo-1,4,2-benzodithiazine. III. Synthesis and diuretic properties of 3-(R,R1-phenyl)amino-6-chloro-7-methyl-1,1-dioxo-1,4,2-benzodithiaz ine s Acta Poloniae Pharmaceutica 42(4): 313-318
Waisser, K.; Gregor, J.; Holý, P.; Kubicová, L.; Klimesová, V.; Kaustová, J. 2001: Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 50(3): 148-152
Harik, S.I.; Schmidley, J.W.; Iacofano, L.A.; Blue, P.; Arora, P.K.; Sayre, L.M. 1987: On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat Journal of Pharmacology and Experimental Therapeutics 241(2): 669-676
Ishimori, T.; Gotanda, K.; Sasaki, T.; Shinbo, A.; Asano, H.; Miyazawa, K.; Miyasaka, K. 1994: Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs Arzneimittel-Forschung 44(5): 583-588
Knowles, J.A.; Ruelius, H.W. 1972: Absorption and excretion of 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one (oxazepam) in humans. Determination of the drug by gas-liquid chromatography with electron capture detection Arzneimittel-Forschung 22(4): 687-692
Kryzhanovskiĭ, G.N.; Atadzhanov, M.A.; Zagorevskiĭ, V.A.; Sharkova, L.M.; Voronina, T.A. 1988: Experimental parkinsonian syndrome in rats induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Biulleten' Eksperimental'noi Biologii i Meditsiny 105(4): 397-401
Sugawara, T.; Yoshida, M.; Shimoda, K.; Takada, S.; Miyamoto, M.; Nomura, M.; Kato, M. 1996: One-month oral toxicity study of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)-9-fluoro-2,3-dihydro-3- methyl-7-oxo-7H-pyrido [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid hemihydrate in rats and cynomolgus monkeys Arzneimittel-Forschung 46(7): 705-710
Alexanian, A.R.; Arutyunian, N.S.; Galoyan, A.A. 1996: Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride Arzneimittel-Forschung 46(12): 1110-1113
Sarles, H.; Camatte, R. 1970: Therapeutic action of phenyl-dimethoxy-2'-4' phenyl-methyl-carbinol and of a vesicular endothelium extract in dyspeptic disorders, fat intolerance and steatorrhea Marseille Medical 107(6): 513-516
Eccles, C.U.; Annau, Z. 1982: Prenatal methyl mercury exposure: II. Alterations in learning and psychotropic drug sensitivity in adult offspring Neurobehavioral Toxicology and Teratology 4(3): 377-382
Chen, S. 1990: Experimental research on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian animal models in the rhesus monkey and C57 black mouse Zhonghua Yi Xue Za Zhi 70(5): 252-254; 18
Fanelli, O. 1973: Pharmacological and toxicological study of a new psychotropic stimulant: the 2-phenyl-5-dimethyl-tetrahydro-1,4-oxazine, in comparison with d,l-amphetamine, phenmetrazine and pemoline-Mg Arzneimittel-Forschung 23(6): 810-816
Sladowska, H.; Zawisza, T. 1986: Synthesis and properties of amides of 1-benzyl-3-methyl- and 1-butyl-3-phenyl-7-methyl-4-oxo-2-thioxo (2,4-dioxo)-1,2,3,4-tetrahydropyrido-[2,3-d]pyrimidine-6-carboxy lic acids Il Farmaco; Edizione Scientifica 41(12): 954-963
Zalewska, A.; Winnicka, M.M.; Wiśniewski, K. 1996: Psychotropic activity of N-methyl-2-amino-4-phosphonobutyric acid (N-methyl AP4) Polish Journal of Pharmacology 48(4): 415-423
Németh, G.áb.; Varga, Z.án.; Greff, Z.án.; Kéri, G.ör.; Orfi, L.ás.ó 2010: Synthesis of 4-Chloro-6-(substituted-phenyl)-pyrimidines Acta Pharmaceutica Hungarica 80(3): 101-108
Wagner, G.; Dietzsch, B.; Krake, U. 1975: Gluco- and xylopyranosides of 3-phenyl-4-methyl-(1,2,4)-triazoline- 5-thiones and 3-phenyl-(1,3,4)-thiadiazoline-5-thiones Die Pharmazie 30(11): 694-698
Hagen, V.; Rumler, A.; Klauschenz, E.; Hagen, A.; Heer, S.; Faust, G.; Mitzner, R. 1990: Potential cardiotonics. 7. Synthesis and cardiovascular effects of 5-(4-pyridinyl)-, 6-methyl-4-(4-pyridinyl) and 6-methyl-5-phenyl-substituted 3-cyano-2-aminoalkylamino-pyridines Die Pharmazie 45(4): 240-241
Badaeva, L.N. 1981: Experimental study of the postnatal neurotoxic effect of chloro-organic pesticides Folia Morphologica 29(2): 113-114
Biniecki, S.; Horoszkiewicz, Z. 1974: Synthesis of indolyl-3-acetic acid (1-phenyl-2-3-dimethyl-5-oxo-4-pyrazolyl) amide of 3-indolylacetic acid and N-methyl-(1-phenyl-2,3-3-indolylacetic acid Acta Poloniae Pharmaceutica 31(2): 151-155